Literature DB >> 21410347

Colorectal cancer screening and prevention in women.

Sandeep Krishnan1, Jacqueline L Wolf.   

Abstract

Colorectal cancer (CRC) is the third most common cause of cancer in women. Screening for CRC increases early detection of cancer and premalignant polyps and decreases morbidity from this disease. However, adherence to the screening guidelines continues to remain inadequate both at the physician and patient levels. Several factors are of special importance to women. Presence of prior gynecological malignancies may increase the risk of CRC in women. Furthermore, new studies have shown other factors such as obesity and smoking to increase the risk of CRC in women. This article highlights issues unique to women with regards to CRC and outlines special considerations for determining screening intervals in women, identifies factors that make screening more difficult in women, and reviews studies that identify preventative strategies which, together with screening, may reduce the burden of CRC.

Entities:  

Mesh:

Year:  2011        PMID: 21410347     DOI: 10.2217/whe.11.7

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  4 in total

1.  Decisional stage distribution for colorectal cancer screening among diverse, low-income study participants.

Authors:  C M Hester; W K Born; H W Yeh; K L Young; A S James; C M Daley; K A Greiner
Journal:  Health Educ Res       Date:  2015-02-25

2.  Estrogen plus progestin and colorectal cancer incidence and mortality.

Authors:  Michael S Simon; Rowan T Chlebowski; Jean Wactawski-Wende; Karen C Johnson; Andrew Muskovitz; Ikuko Kato; Alicia Young; F Allan Hubbell; Ross L Prentice
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

3.  Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients.

Authors:  Rosa Schmuck; Michael Gerken; Eva-Maria Teegen; Isabell Krebs; Monika Klinkhammer-Schalke; Felix Aigner; Johann Pratschke; Beate Rau; Stefan Benz
Journal:  Langenbecks Arch Surg       Date:  2020-01-31       Impact factor: 3.445

4.  Predicting the progress of colon cancer by DNA methylation markers of the p16 gene in feces - Evidence from an animal model.

Authors:  Wen-Chih Wu; Chih-Hsiung Hsu; Jen-Chun Kuan; Jih-Fu Hsieh; Chien-An Sun; Tsan Yang; Chang-Chieh Wu; Yu-Ching Chou
Journal:  Genet Mol Biol       Date:  2013-08-30       Impact factor: 1.771

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.